Revolutionary drug that prevents hot flushes during menopause approved for use in the UK
A new drug that aims to prevent hot flushes will soon be for use in the UK.
Veoza, also known as fezolinetant, has been approved by the UK regulator, potentially benefiting millions of women. The drug was approved for use seven months ago in America by the US regulator, the Food and Drug Administration.
Hot flushes affect around 70 per cent of women going through the. Symptoms can last for months or years and can change with time.
